These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 27288730)

  • 1. Metabolic signatures of Huntington's disease (HD): (1)H NMR analysis of the polar metabolome in post-mortem human brain.
    Graham SF; Kumar PK; Bjorndahl T; Han B; Yilmaz A; Sherman E; Bahado-Singh RO; Wishart D; Mann D; Green BD
    Biochim Biophys Acta; 2016 Sep; 1862(9):1675-84. PubMed ID: 27288730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolite mapping reveals severe widespread perturbation of multiple metabolic processes in Huntington's disease human brain.
    Patassini S; Begley P; Xu J; Church SJ; Reid SJ; Kim EH; Curtis MA; Dragunow M; Waldvogel HJ; Snell RG; Unwin RD; Faull RL; Cooper GJ
    Biochim Biophys Acta; 2016 Sep; 1862(9):1650-62. PubMed ID: 27267344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurochemical changes in the progression of Huntington's disease: A meta-analysis of in vivo
    Jing Y; Dogan I; Reetz K; Romanzetti S
    Neurobiol Dis; 2024 Sep; 199():106574. PubMed ID: 38914172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal investigation of changes in resting-state co-activation patterns and their predictive ability in the zQ175 DN mouse model of Huntington's disease.
    Adhikari MH; Vasilkovska T; Cachope R; Tang H; Liu L; Keliris GA; Munoz-Sanjuan I; Pustina D; Van der Linden A; Verhoye M
    Sci Rep; 2023 Jun; 13(1):10194. PubMed ID: 37353500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative Proteomic Analysis Reveals Similarities between Huntington's Disease (HD) and Huntington's Disease-Like 2 (HDL2) Human Brains.
    Ratovitski T; Chaerkady R; Kammers K; Stewart JC; Zavala A; Pletnikova O; Troncoso JC; Rudnicki DD; Margolis RL; Cole RN; Ross CA
    J Proteome Res; 2016 Sep; 15(9):3266-83. PubMed ID: 27486686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An exploratory metabolomic comparison of participants with fast or absent functional progression from 2CARE, a randomized, double-blind clinical trial in Huntington's disease.
    McGarry A; Hunter K; Gaughan J; Auinger P; Ferraro TN; Pradhan B; Ferrucci L; Egan JM; Moaddel R
    Sci Rep; 2024 Jan; 14(1):1101. PubMed ID: 38212353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GLUT-1 changes in paediatric Huntington disease brain cortex and fibroblasts: an observational case-control study.
    Tramutola A; Bakels HS; Perrone F; Di Nottia M; Mazza T; Abruzzese MP; Zoccola M; Pagnotta S; Carrozzo R; de Bot ST; Perluigi M; van Roon-Mom WMC; Squitieri F
    EBioMedicine; 2023 Nov; 97():104849. PubMed ID: 37898095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo imaging of brain glutamate defects in a knock-in mouse model of Huntington's disease.
    Pépin J; Francelle L; Carrillo-de Sauvage MA; de Longprez L; Gipchtein P; Cambon K; Valette J; Brouillet E; Flament J
    Neuroimage; 2016 Oct; 139():53-64. PubMed ID: 27318215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted biochemical profiling of brain from Huntington's disease patients reveals novel metabolic pathways of interest.
    Graham SF; Pan X; Yilmaz A; Macias S; Robinson A; Mann D; Green BD
    Biochim Biophys Acta Mol Basis Dis; 2018 Jul; 1864(7):2430-2437. PubMed ID: 29684586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated multi-omics analysis of Huntington disease identifies pathways that modulate protein aggregation.
    Pradhan SS; Thota SM; Rajaratnam S; Bhagavatham SKS; Pulukool SK; Rathnakumar S; Phalguna KS; Dandamudi RB; Pargaonkar A; Joseph P; Joshy EV; Sivaramakrishnan V
    Dis Model Mech; 2022 Oct; 15(10):. PubMed ID: 36052548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomics: An Emerging "Omics" Platform for Systems Biology and Its Implications for Huntington Disease Research.
    Akyol S; Ashrafi N; Yilmaz A; Turkoglu O; Graham SF
    Metabolites; 2023 Dec; 13(12):. PubMed ID: 38132886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The longitudinal biochemical profiling of TBI in a drop weight model of TBI.
    Yilmaz A; Liraz-Zaltsman S; Shohami E; Gordevičius J; Kerševičiūtė I; Sherman E; Bahado-Singh RO; Graham SF
    Sci Rep; 2023 Dec; 13(1):22260. PubMed ID: 38097614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral administration of S-nitroso-L-glutathione (GSNO) provides anti-inflammatory and cytoprotective effects during ocular bacterial infections.
    Das S; Ahmad Z; Singh S; Singh S; Wright RE; Giri S; Kumar A
    Cell Mol Life Sci; 2023 Sep; 80(10):309. PubMed ID: 37770649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrative Analysis Unveils the Correlation of Aminoacyl-tRNA Biosynthesis Metabolites with the Methylation of the
    Vishweswaraiah S; Yilmaz A; Saiyed N; Khalid A; Koladiya PR; Pan X; Macias S; Robinson AC; Mann D; Green BD; Kerševičiūte I; Gordevičius J; Radhakrishna U; Graham SF
    Genes (Basel); 2023 Sep; 14(9):. PubMed ID: 37761892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress, dysfunctional energy metabolism, and destabilizing neurotransmitters altered the cerebral metabolic profile in a rat model of simulated heliox saturation diving to 4.0 MPa.
    Liu X; Fang Y; Xu J; Yang T; Xu J; He J; Liu W; Yu X; Wen Y; Zhang N; Li C
    PLoS One; 2023; 18(3):e0282700. PubMed ID: 36917582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin B
    Pradhan SS; Rao KR; Manjunath M; Saiswaroop R; Patnana DP; Phalguna KS; Choudhary B; Sivaramakrishnan V
    3 Biotech; 2023 Mar; 13(3):96. PubMed ID: 36852176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain Alterations in Aged OVT73 Sheep Model of Huntington's Disease: An MRI Based Approach.
    Taghian T; Gallagher J; Batcho E; Pullan C; Kuchel T; Denney T; Perumal R; Moore S; Muirhead R; Herde P; Johns D; Christou C; Taylor A; Passler T; Pulaparthi S; Hall E; Chandra S; O'Neill CA; Gray-Edwards H
    J Huntingtons Dis; 2022; 11(4):391-406. PubMed ID: 36189602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylated Cytochrome P450 and the Solute Carrier Family of Genes Correlate With Perturbations in Bile Acid Metabolism in Parkinson's Disease.
    Vishweswaraiah S; Akyol S; Yilmaz A; Ugur Z; Gordevičius J; Oh KJ; Brundin P; Radhakrishna U; Labrie V; Graham SF
    Front Neurosci; 2022; 16():804261. PubMed ID: 35431771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe and Regionally Widespread Increases in Tissue Urea in the Human Brain Represent a Novel Finding of Pathogenic Potential in Parkinson's Disease Dementia.
    Scholefield M; Church SJ; Xu J; Patassini S; Roncaroli F; Hooper NM; Unwin RD; Cooper GJS
    Front Mol Neurosci; 2021; 14():711396. PubMed ID: 34751215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain Branched-Chain Amino Acids in Maple Syrup Urine Disease: Implications for Neurological Disorders.
    Xu J; Jakher Y; Ahrens-Nicklas RC
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.